Table 3 Association of dysregulated genes with clinical outcomes in PCa of AA compared to CA patients.

From: Dysregulated gene expression predicts tumor aggressiveness in African-American prostate cancer patients

 

Age

PSA

Prostate Volume

T stage

% Positive Cores

% Involvement

APPL2

0.253

0.258

0.182

0.775

0.007*

0.054

ALDH1A3

0.156

0.388

0.049*

0.545

0.074

0.038*

AMD1

0.098

0.470

0.041*

0.583

0.024*

0.430

LTC4S

0.219

0.352

0.192

0.871

0.475

0.126

NKX3.1

0.081

0.374

0.207

0.626

0.199

0.103

OAT

0.077

0.497

0.022*

0.301

0.813

0.867

TPD52

0.205

0.383

0.140

0.486

0.025*

0.581

  1. PSA: Prostate-specific antigen. Data represents p-values calculated by Mann-Whitney to correlate gene expression levels (median ΔCT) with clinical characteristics of PCa patients. *Depicts statistical significance at p < 0.05.
Back to article page